{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:11:40Z","timestamp":1788844300838,"version":"build-2803163510"},"reference-count":78,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1001\/jamapsychiatry.2018.2309","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T19:32:44Z","timestamp":1535657564000},"page":"1107","source":"Crossref","is-referenced-by-count":142,"title":["Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis"],"prefix":"10.1001","volume":"75","author":[{"given":"Sagnik","family":"Bhattacharyya","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Appiah-Kusi","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brammer","sequence":"additional","affiliation":[{"name":"Centre for Neuroimaging Sciences, Department of Neuroimaging, Institute of Psychiatry, Psychology, and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Perez","sequence":"additional","affiliation":[{"name":"CAMEO Early Intervention Service, Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Department of Psychology, University of Roehampton, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs G.","family":"Bossong","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"},{"name":"Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9584","key":"yoi180060r1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"yoi180060r2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","article-title":"Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"yoi180060r3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"yoi180060r4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamapsychiatry.2016.2427","article-title":"Association between continued cannabis use and risk of relapse in first-episode psychosis: a quasi-experimental investigation within an observational study.","volume":"73","author":"Schoeler","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi180060r5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0033291715001786","article-title":"Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids.","volume":"46","author":"Appiah-Kusi","year":"2016","journal-title":"Psychol Med"},{"issue":"12","key":"yoi180060r6","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.biopsych.2015.08.021","article-title":"Reduced brain cannabinoid receptor availability in schizophrenia.","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"7","key":"yoi180060r7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.biopsych.2015.11.018","article-title":"Therapeutic potential of cannabinoids in psychosis.","volume":"79","author":"Leweke","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"3","key":"yoi180060r8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.","volume":"30","author":"Zuardi","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"issue":"1","key":"yoi180060r9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/cercor\/bhj136","article-title":"Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.","volume":"17","author":"Eggan","year":"2007","journal-title":"Cereb Cortex"},{"issue":"2","key":"yoi180060r10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"2","key":"yoi180060r11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"8","key":"yoi180060r12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"yoi180060r13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archgenpsychiatry.2009.17","article-title":"Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.","volume":"66","author":"Bhattacharyya","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi180060r14","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/mp.2011.187","article-title":"Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of d-9-tetrahydrocannabinol on midbrain and striatal function.","volume":"17","author":"Bhattacharyya","year":"2012","journal-title":"Mol Psychiatry"},{"issue":"6","key":"yoi180060r15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.","volume":"57","author":"D\u2019Souza","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"7","key":"yoi180060r16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies.","volume":"259","author":"D\u2019Souza","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"yoi180060r17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi180060r18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archgenpsychiatry.2011.161","article-title":"Induction of psychosis by ?9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.","volume":"69","author":"Bhattacharyya","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"yoi180060r19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/npp.2014.258","article-title":"Cannabinoid modulation of functional connectivity within regions processing attentional salience.","volume":"40","author":"Bhattacharyya","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi180060r20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.","volume":"27","author":"Englund","year":"2013","journal-title":"J Psychopharmacol"},{"issue":"3","key":"yoi180060r21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","article-title":"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.","volume":"25","author":"Hindocha","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"yoi180060r22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.","volume":"192","author":"Morgan","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"4","key":"yoi180060r23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study","volume":"197","author":"Morgan","year":"2010","journal-title":"Br J Psychiatry"},{"issue":"6","key":"yoi180060r24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients.","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yoi180060r25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"yoi180060r26","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"issue":"3","key":"yoi180060r27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial.","volume":"175","author":"McGuire","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"11-12","key":"yoi180060r28","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","article-title":"Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.","volume":"39","author":"Yung","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"yoi180060r29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.psychres.2015.05.018","article-title":"Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?","volume":"228","author":"Falkenberg","year":"2015","journal-title":"Psychiatry Res"},{"issue":"3","key":"yoi180060r30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tins.2014.12.005","article-title":"Translating the MAM model of psychosis to humans.","volume":"38","author":"Modinos","year":"2015","journal-title":"Trends Neurosci"},{"issue":"5","key":"yoi180060r31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/archgenpsychiatry.2011.42","article-title":"Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study.","volume":"68","author":"Mechelli","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"yoi180060r32","article-title":"Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: replication in a second cohort","author":"Allen","journal-title":"Schizophr Bull"},{"issue":"4","key":"yoi180060r33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1176\/appi.ajp.2015.15040485","article-title":"Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis.","volume":"173","author":"Allen","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"5","key":"yoi180060r34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/schbul\/sbr017","article-title":"Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis.","volume":"38","author":"Allen","year":"2012","journal-title":"Schizophr Bull"},{"issue":"24","key":"yoi180060r35","doi-asserted-by":"publisher","first-page":"13515","DOI":"10.1073\/pnas.93.24.13515","article-title":"Structure and function of declarative and nondeclarative memory systems.","volume":"93","author":"Squire","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"49","key":"yoi180060r36","doi-asserted-by":"publisher","first-page":"19900","DOI":"10.1073\/pnas.1116727109","article-title":"Role of prefrontal cortex and the midbrain dopamine system in working memory updating.","volume":"109","author":"D\u2019Ardenne","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"yoi180060r37","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1523\/JNEUROSCI.3463-05.2006","article-title":"The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging.","volume":"26","author":"Schott","year":"2006","journal-title":"J Neurosci"},{"issue":"4","key":"yoi180060r38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1101\/lm.75004","article-title":"Activation of midbrain structures by associative novelty and the formation of explicit memory in humans.","volume":"11","author":"Schott","year":"2004","journal-title":"Learn Mem"},{"issue":"3","key":"yoi180060r39","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.neuroimage.2011.05.006","article-title":"Selective updating of working memory content modulates meso-cortico-striatal activity.","volume":"57","author":"Murty","year":"2011","journal-title":"Neuroimage"},{"issue":"3","key":"yoi180060r40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/ejn.2004.19.issue-3","article-title":"Striatal contributions to working memory: a functional magnetic resonance imaging study in humans.","volume":"19","author":"Lewis","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"5882","key":"yoi180060r41","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.1155466","article-title":"Transfer of learning after updating training mediated by the striatum.","volume":"320","author":"Dahlin","year":"2008","journal-title":"Science"},{"issue":"1","key":"yoi180060r42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nn2024","article-title":"Prefrontal cortex and basal ganglia control access to working memory.","volume":"11","author":"McNab","year":"2008","journal-title":"Nat Neurosci"},{"issue":"2","key":"yoi180060r43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/cercor\/bhn095","article-title":"Striatal dopamine and working memory.","volume":"19","author":"Landau","year":"2009","journal-title":"Cereb Cortex"},{"issue":"7","key":"yoi180060r45","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0730-725X(97)00135-5","article-title":"Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach.","volume":"15","author":"Brammer","year":"1997","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"yoi180060r46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuroimage.2006.11.054","article-title":"Analysis of a large fMRI cohort: statistical and methodological issues for group analyses.","volume":"35","author":"Thirion","year":"2007","journal-title":"Neuroimage"},{"issue":"1","key":"yoi180060r47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(ISSN)1097-0193","article-title":"Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI.","volume":"7","author":"Bullmore","year":"1999","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"yoi180060r48","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1053-8119(03)00077-6","article-title":"Adaptive analysis of fMRI data.","volume":"19","author":"Friman","year":"2003","journal-title":"Neuroimage"},{"issue":"2","key":"yoi180060r49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(ISSN)1097-0193","article-title":"Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains.","volume":"12","author":"Bullmore","year":"2001","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"yoi180060r50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1109\/42.750253","article-title":"Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain.","volume":"18","author":"Bullmore","year":"1999","journal-title":"IEEE Trans Med Imaging"},{"key":"yoi180060r52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jpsychires.2014.08.018","article-title":"Exploring neural dysfunction in \u2018clinical high risk\u2019 for psychosis: a quantitative review of fMRI studies.","volume":"61","author":"Dutt","year":"2015","journal-title":"J Psychiatr Res"},{"issue":"pt B","key":"yoi180060r53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuroimage.2016.03.075","article-title":"Using neuroimaging to help predict the onset of psychosis.","volume":"145","author":"Gifford","year":"2017","journal-title":"Neuroimage"},{"key":"yoi180060r54","first-page":"1","article-title":"Neuroimaging biomarkers for psychosis.","volume":"2015","author":"Hager","year":"2015","journal-title":"Curr Behav Neurosci Rep"},{"issue":"8","key":"yoi180060r55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression.","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"42","key":"yoi180060r56","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.","volume":"27","author":"Lodge","year":"2007","journal-title":"J Neurosci"},{"issue":"6","key":"yoi180060r57","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/schbul\/sbr194","article-title":"Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.","volume":"38","author":"Allen","year":"2012","journal-title":"Schizophr Bull"},{"issue":"9","key":"yoi180060r58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/mp.2011.20","article-title":"Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.","volume":"16","author":"Howes","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"12","key":"yoi180060r59","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","article-title":"Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.","volume":"168","author":"Howes","year":"2011","journal-title":"Am J Psychiatry"},{"key":"yoi180060r60","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-3-319-20825-1","article-title":"Cannabis and endocannabinoid signaling in epilepsy.","volume":"231","author":"Katona","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"1-3","key":"yoi180060r61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans.","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr Res"},{"issue":"4","key":"yoi180060r62","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"5","key":"yoi180060r63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"13","key":"yoi180060r64","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1073\/pnas.1211204110","article-title":"Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses.","volume":"110","author":"Sylantyev","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"yoi180060r65","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1476-5381.2010.01015.x","article-title":"Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways.","volume":"162","author":"Ledgerwood","year":"2011","journal-title":"Br J Pharmacol"},{"key":"yoi180060r66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors.","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"issue":"47","key":"yoi180060r67","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances.","volume":"29","author":"Ren","year":"2009","journal-title":"J Neurosci"},{"key":"yoi180060r68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.30.051606.094328","article-title":"The medial temporal lobe and recognition memory.","volume":"30","author":"Eichenbaum","year":"2007","journal-title":"Annu Rev Neurosci"},{"key":"yoi180060r69","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbr.2013.05.029","article-title":"Dissociable neural correlates of item and context retrieval in the medial temporal lobes.","volume":"254","author":"Wang","year":"2013","journal-title":"Behav Brain Res"},{"issue":"2","key":"yoi180060r70","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00001756-200102120-00035","article-title":"Hippocampal, parahippocampal and occipital-temporal contributions to associative and item recognition memory: an fMRI study.","volume":"12","author":"Yonelinas","year":"2001","journal-title":"Neuroreport"},{"issue":"2","key":"yoi180060r71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1023870821631","article-title":"Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.","volume":"13","author":"Cirillo","year":"2003","journal-title":"Neuropsychol Rev"},{"issue":"11","key":"yoi180060r72","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.biopsych.2006.03.043","article-title":"Associative memory encoding and recognition in schizophrenia: an event-related fMRI study.","volume":"60","author":"Lepage","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"yoi180060r73","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jamapsychiatry.2013.3911","article-title":"Altered hippocampal-parahippocampal function during stimulus encoding: a potential indicator of genetic liability for schizophrenia.","volume":"71","author":"Rasetti","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi180060r74","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biopsych.2010.08.033","article-title":"Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis.","volume":"69","author":"Valli","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"4","key":"yoi180060r75","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.biopsych.2006.04.044","article-title":"Elaborative verbal encoding and altered anterior parahippocampal activation in adolescents and young adults at genetic risk for schizophrenia using FMRI.","volume":"61","author":"Thermenos","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yoi180060r76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hbm.23844","article-title":"An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers.","volume":"39","author":"Hawkins","year":"2018","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"yoi180060r77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pscychresns.2005.02.006","article-title":"Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.","volume":"139","author":"Lahti","year":"2005","journal-title":"Psychiatry Res"},{"issue":"3","key":"yoi180060r78","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/schbul\/sbm018","article-title":"Cognitive functioning in the schizophrenia prodrome.","volume":"33","author":"Simon","year":"2007","journal-title":"Schizophr Bull"},{"key":"yoi180060r44","volume-title":"Manual for the State\/Trait Anxiety Inventory (Form Y) (Self Evaluation Questionnaire)","author":"Spielberger","year":"1983"},{"key":"yoi180060r51","volume-title":"Co-planar Stereotaxic Atlas of the Human Brain: 3-D Proportional System: An Approach to Cerebral Imaging","author":"Talairach","year":"1988"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2697762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T11:00:44Z","timestamp":1541588444000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.2309"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.2309","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}